{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:32:08Z","timestamp":1761093128620,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.urolonc.2020.08.008","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T08:09:01Z","timestamp":1599379741000},"page":"132.e13-132.e26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage"],"prefix":"10.1016","volume":"39","author":[{"given":"Chuan-Shu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shian-Shiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Ri","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Kuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Li","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Yuan","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun-Fa","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.08.008_bib0001","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0002","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update","volume":"73","author":"Roupret","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0003","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0004","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1245\/s10434-014-3830-3","article-title":"A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy","volume":"21","author":"Tanaka","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","article-title":"Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature","volume":"62","author":"Lughezzani","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0006","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/JU.0000000000000422","article-title":"Impact of previous, simultaneous or subsequent bladder cancer on prognosis after radical nephroureterectomy for upper urinary tract urothelial carcinoma","volume":"202","author":"Kuroiwa","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0007","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3349\/ymj.2019.60.2.174","article-title":"Prognostic value of lymphovascular invasion in node-negative upper urinary tract urothelial carcinoma patients undergoing radical nephroureterectomy","volume":"60","author":"Liu","year":"2019","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0008","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.juro.2010.03.030","article-title":"Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma","volume":"184","author":"Brien","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0009","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1200\/JCO.2006.07.1092","article-title":"Role of lymphangiogenesis in cancer","volume":"25","author":"Sundar","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0010","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/bju.12116","article-title":"Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy","volume":"111","author":"Hurel","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0011","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.eururo.2009.12.029","article-title":"Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study","volume":"57","author":"Novara","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0012","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2008.17.2361","article-title":"Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma","volume":"27","author":"Kikuchi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0013","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.juro.2007.08.019","article-title":"Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically","volume":"178","author":"Saito","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2015.06.016","article-title":"Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study","volume":"33","author":"Mathieu","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0015","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1245\/s10434-012-2453-9","article-title":"Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival","volume":"19","author":"Colin","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0016","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.21873\/anticanres.11525","article-title":"Comparison of efficacy of adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in advanced upper tract urothelial carcinoma","volume":"37","author":"Hung","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0017","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0018","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1200\/JCO.2016.69.4141","article-title":"Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and\/or positive regional lymph node upper tract urothelial carcinoma","volume":"35","author":"Seisen","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0019","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.6_suppl.407","article-title":"Results of POUT: a phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)","volume":"36","author":"Birtle","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.urology.2006.10.014","article-title":"Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract","volume":"69","author":"Kondo","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0021","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1442-2042.2006.01664.x","article-title":"Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer","volume":"14","author":"Secin","year":"2007","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0022","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.eururo.2008.01.008","article-title":"Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract","volume":"53","author":"Roscigno","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0023","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/j.ejca.2013.04.016","article-title":"Lymphovascular invasion as a prognostic factor in the upper urinary tract urothelial carcinoma: a systematic review and meta-analysis","volume":"49","author":"Ku","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0024","unstructured":"ABC"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0025","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.juro.2014.10.022","article-title":"Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience","volume":"193","author":"Shirotake","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0026","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.7150\/jca.34103","article-title":"Role of adjuvant chemotherapy in advanced stage upper urinary tract urothelial carcinoma after radical nephroureterectomy: competing risk analysis after propensity score-matching","volume":"10","author":"Kang","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0027","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1002\/cncr.26172","article-title":"Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study","volume":"117","author":"Vassilakopoulou","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.08.008_bib0028","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.juro.2009.05.011","article-title":"Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the upper tract urothelial carcinoma collaboration","volume":"182","author":"Hellenthal","year":"2009","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920303756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920303756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:19:09Z","timestamp":1761041949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920303756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1078143920303756"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.08.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}